neuraminidase inhibitors (GlaxoSmithKline)

N/A

Report date: 2025/03/20 15:03:08
NME

Base Information

Drug Nameneuraminidase inhibitors (GlaxoSmithKline)
Drug Alias Nameinfluenza therapy (GlaxoSmithKline)neuraminidase inhibitors (Glaxo Wellcome)influenza therapy (Glaxo Wellcome)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxo Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcGlaxo Group Ltd
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A